Search results
FDA Approves Expanded Use Of Bristol Myers Squibb's Breyanzi Cancer Cell Therapy For Previously...
Benzinga· 20 hours agoThis indication is approved under accelerated approval based on response rate and duration of...
Bristol Myers (BMY) Gets FDA Nod for Breyanzi Label Expansion
Zacks via Yahoo Finance· 23 hours agoBristol Myers Squibb (BMY) obtains FDA approval for the label expansion of CAR T cell therapy...
FDA approves Bristol Myers Squibb’s Breyanzi for follicular lymphoma
Pharmaceutical Technology via Yahoo Finance· 1 day ago"FDA approves Bristol Myers Squibb’s Breyanzi for follicular lymphoma" was originally created and...
US FDA approves expanded use of Bristol Myers' cancer cell therapy (May 15)
Reuters via AOL· 2 days agoThe U.S. health regulator on Wednesday approved the expanded use of Bristol Myers Squibb's cancer...
Bristol Myers Gets FDA OK of Breyanzi in Follicular Lymphoma
Morningstar· 1 day agoThe Princeton, N.J., biopharmaceutical company late Wednesday said the FDA granted accelerated approval for the new indication, adding that continued approval may be contingent ...
Cytokinetics Reverses Higher On 'Pristine' Results For Bristol Myers-Rivaling Heart Drug
Investor's Business Daily· 3 days agoThe aficamten treatment group also had an 80% reduction in a biomarker of cardiac wall stress...
Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
Zacks via Yahoo Finance· 19 hours agoUpdates from BMY: Bristol Myers BMY announced that the FDA had granted accelerated approval to the...
Immunotherapy may boost survival after lung cancer surgery
UPI· 20 hours agoImmunotherapy can boost the survival of early-stage lung cancer patients eligible for surgery when...
KRAS inhibitors: The next frontier beckons
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe FDA accepted a supplemental new drug application for the combination treatment in February 2024 for previously treated KRAS ...very cautiously...
Biogen Continues Its 20% Sprint On A Twist In Alzheimer's Treatment
Investor's Business Daily· 2 days agoThe companies are submitting information on a rolling basis for approval of an under-the-skin...